Impact of IVIg on the interaction between activated T cells and microglia

Neurological Research

Volumn 28, Issue 3, 2006, Pages 270-274

  Janke, Angela D ^a   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Microglia; Multiple sclerosis; Neuroimmunology; T cells; Therapeutics

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FETUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; MICROGLIA; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE ACTIVATION;

ANALYSIS OF VARIANCE; CELL COMMUNICATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETUS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-10; MICROGLIA; MODELS, BIOLOGICAL; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646809305     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X98143     Document Type: Article

References (30)

1. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol 1999; 57: 563-581
2. Chabot S, Williams G, Yong VW. Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b. J Clin Invest 1997; 100: 604-612
3. Chabot S, Williams G, Hamilton M, et al. Mechanisms of IL-10 production in human microglia-T cell interaction. J Immunol 1999; 162: 6819-6828
4. Giuliani F, Hader W, Yong VW. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leuk Biol 2005; 78: 135-143
5. Sedgwick JD, Ford AL, Foulcher E, et al. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. J Immunol 1998; 160: 5320-5330
6. Raivich G, Jones LL, Kloss CU, et al. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 1998; 18: 5804-5818
7. Benner EJ, Mosley RL, Destache CJ, et al. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 2004; 101: 9435-9440
8. Jack C, Ruffini F, Bar-Or A, et al. Microglia and multiple sclerosis. J Neurosci Res 2005; 81: 363-373
9. Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res 2005; 81: 302-313
10. Neumann H, Medana IM, Bauer J, et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002; 25: 313-319
11. Giuliani F, Goodyer CG, Antel JP, et al. Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 2003; 171: 368-379
12. Prineas JW, Kwon EE, Cho ES, et al. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 2001; 50: 646-657
13. Kim HJ, Ifergan I, Antel JP, et al. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J Immunol 2004; 172: 7144-7153
14. Carson MJ, Sutcliffe JG, Campbell IL. Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J Neurosci Res 1999; 55: 127-134
15. Aloisi F, Ria F, Penna G, et al. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 activation. J Immunol 1998; 160: 4671-4680
16. Ford AL, Foulcher E, Lemckert FA, et al. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 1996; 184: 1737-1745
17. Matyszak MK, Denis-Donini S, Citterio S, et al. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. Eur J Immunol 1999; 29: 3063-3076
18. Gimsa U, Peter SV, Lehmann K, et al. Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: Involvement of microglial cells. Brain Pathol 2000; 10: 365-377
19. Sedgwick JD, Ford AL, Foulcher E, et al. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. J Immunol 1998; 160: 5320-5330
20. Pirko I, Johnson A, Ciric B, et al. In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J 2004; 18: 179-182
21. Humle Jorgensen S, Sorensen PS. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. J Neurol Sci 2005; 233: 61-65
22. Warrington AE, Bieber AJ, Ciric B, et al. Immunoglobulin-mediated CNS repair. J Allergy Clin Immunol 2001; 108: S121-S125
23. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339-346
24. Jurewicz A, Matysiak M, Tybor K, et al. Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 2005; 128: 2675-2688
25. Arnett HA, Mason J, Marino M, et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 2001; 4: 1116-1122
26. Akdis CA, Blesken T, Akdis M, et al. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106
27. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-1555
28. Menendez Iglesias B, Cerase J, Ceracchini C, et al. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: Upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. J Neuroimmunol 1997; 72: 83-93
29. Wogensen L, Huang X, Sarvernick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993; 178: 175-185
30. Chabot S, Yong FP, Le DM, et al. Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: A mechanism for therapeutic efficacy in multiple sclerosis. Mult Scler 2002; 8: 299-306